The_DT
role_NN
of_IN
nuclear_JJ
factor-kappa_NN
B_NN
in_IN
cytokine_NN
gene_NN
regulation_NN
._.

Transcription_NN
factors_NNS
are_VBP
DNA-binding_JJ
proteins_NNS
that_WDT
regulate_VBP
gene_NN
expression_NN
._.

Nuclear_JJ
factor-kappa_NN
B_NN
-LRB-_-LRB-
NF-kappa_NN
B_NN
-RRB-_-RRB-
is_VBZ
a_DT
critical_JJ
transcription_NN
factor_NN
for_IN
maximal_JJ
expression_NN
of_IN
many_JJ
cytokines_NNS
that_WDT
are_VBP
involved_VBN
in_IN
the_DT
pathogenesis_NN
of_IN
inflammatory_JJ
diseases_NNS
,_,
such_JJ
as_IN
adult_JJ
respiratory_JJ
distress_NN
syndrome_NN
-LRB-_-LRB-
ARDS_NN
-RRB-_-RRB-
and_CC
sepsis_NN
syndrome_NN
._.

Activation_NN
and_CC
regulation_NN
of_IN
NF-kappa_NN
B_NN
are_VBP
tightly_RB
controlled_VBN
by_IN
a_DT
group_NN
of_IN
inhibitory_JJ
proteins_NNS
-LRB-_-LRB-
I_NN
kappa_NN
B_NN
-RRB-_-RRB-
that_WDT
sequester_VBP
NF-kappa_NN
B_NN
in_IN
the_DT
cytoplasm_NN
of_IN
immune\/inflammatory_JJ
effector_NN
cells_NNS
._.

NF-kappa_NN
B_NN
activation_NN
involves_VBZ
signaled_VBN
phosphorylation_NN
,_,
ubiquitination_NN
,_,
and_CC
proteolysis_NN
of_IN
I_NN
kappa_NN
B_NN
._.

Liberated_VBN
NF-kappa_NN
B_NN
migrates_VBZ
to_TO
the_DT
nucleus_NN
,_,
where_WRB
it_PRP
binds_VBZ
to_TO
specific_JJ
promoter_NN
sites_NNS
and_CC
activates_VBZ
gene_NN
transcription_NN
._.

The_DT
activation_NN
of_IN
NF-kappa_NN
B_NN
initiates_VBZ
both_CC
extracellular_JJ
and_CC
intracellular_JJ
regulatory_JJ
events_NNS
that_WDT
result_VBP
in_IN
autoregulation_NN
of_IN
the_DT
inflammatory_JJ
cascade_NN
through_IN
modulation_NN
of_IN
NF-kappa_NN
B_NN
activation_NN
._.

Recently_RB
,_,
activation_NN
of_IN
NF-kappa_NN
B_NN
has_VBZ
been_VBN
linked_VBN
to_TO
ARDS_NN
and_CC
has_VBZ
been_VBN
shown_VBN
to_TO
be_VB
a_DT
critical_JJ
proximal_JJ
step_NN
in_IN
the_DT
initiation_NN
of_IN
neutrophilic_JJ
inflammation_NN
in_IN
animal_JJ
models_NNS
._.

Activation_NN
of_IN
NF-kappa_NN
B_NN
can_MD
be_VB
inhibited_VBN
in_FW
vivo_FW
by_IN
treatment_NN
with_IN
antioxidants_NNS
,_,
corticosteroids_NNS
,_,
and_CC
the_DT
induction_NN
of_IN
endotoxin_NN
tolerance_NN
._.

Identification_NN
of_IN
more_RBR
specific_JJ
and_CC
efficacious_JJ
inhibitors_NNS
of_IN
NF-kappa_NN
B_NN
activation_NN
might_MD
prove_VB
beneficial_JJ
for_IN
the_DT
treatment_NN
of_IN
cytokine-mediated_JJ
inflammatory_JJ
diseases_NNS
._.

